Clinical trial
Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers. Closure Obtained With Vascularized Epithelial Regeneration for DFUs With SkinTE® II (COVER DFUS II)
NCT06140303 is registered in ClinicalTrials.gov with PolarityTE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers. Closure Obtained With Vascularized Epithelial Regeneration for DFUs With SkinTE® II (COVER DFUS II)
- Lead sponsor
- PolarityTE
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- February 22, 2024
- Completion date
- March 31, 2026
- Enrollment
- 100 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.